ANET vs APH
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ANET exhibits strong financial health with a Piotroski F-Score of 8/9, indicating robust operational performance and balance sheet strength. Despite this, the stock trades at a significant premium to both the Graham Number ($23.47) and intrinsic value estimate ($76.41), currently priced at $136.34, reflecting high growth expectations. Solid profitability metrics—such as a 39.73% profit margin and 31.74% ROE—are offset by rich valuation multiples and bearish insider activity, including $26.43M in net selling over the past six months. While earnings have consistently beaten estimates with strong YoY growth (25.0%), the lack of dividend and elevated P/E (52.64) relative to peers suggest limited margin of safety.
Amphenol Corporation exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust fundamentals. The company delivers exceptional profitability metrics, including a 34.81% ROE and 27.48% operating margin, alongside explosive year-over-year revenue and earnings growth. However, the stock trades at a steep valuation (P/E of 50.84 vs. sector average of 89.67) and shows bearish insider activity, with $140.28M in net insider selling over the past six months. While growth and profitability are compelling, elevated multiples and insider selling temper immediate upside potential.
Compare Another Pair
Related Comparisons
ANET vs APH: Head-to-Head Comparison
This page compares Arista Networks, Inc. (ANET) and Amphenol Corporation (APH) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.